BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28657224)

  • 1. Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.
    Shim SH; Kim H; Sohn IS; Hwang HS; Kwon HS; Lee SJ; Lee JY; Kim SN; Lee K; Chang S
    J Gynecol Oncol; 2017 Sep; 28(5):e63. PubMed ID: 28657224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance.
    Kim H; Kim KY; Kim D; Hwang JH
    J Gynecol Oncol; 2024 May; 35(3):e26. PubMed ID: 38130135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
    Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
    Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
    Massad LS; Xie X; Minkoff HL; Michel KG; D'Souza G; Wang CC; Konkle-Parker D; Ofotokun I; Fischl MA; Rahangdale L; Strickler HD
    Am J Obstet Gynecol; 2021 Oct; 225(4):411.e1-411.e7. PubMed ID: 33957115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.
    Han MA; Choi KS; Lee HY; Jun JK; Jung KW; Kang S; Park EC
    PLoS One; 2012; 7(4):e35469. PubMed ID: 22530028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana.
    Donkoh ET; Agyemang-Yeboah F; Asmah RH; Wiredu EK
    Medicine (Baltimore); 2019 Mar; 98(13):e14600. PubMed ID: 30921178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study.
    Kim M; Kim H; Suh DH; Kim YB
    Cancer Res Treat; 2021 Jul; 53(3):813-818. PubMed ID: 33321565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
    Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
    J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
    Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
    Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
    Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
    Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009.
    Park MJ; Park EC; Choi KS; Jun JK; Lee HY
    BMC Cancer; 2011 Jun; 11():257. PubMed ID: 21682886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
    Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
    J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cervical cancer screening results among public and private services in Brazil.
    Bispo Pereira EH; Camilo-Júnior DJ; D'ávilla SCGP; Mattar NJ; Xavier-Júnior JCC
    Int J Gynaecol Obstet; 2022 Aug; 158(2):289-294. PubMed ID: 34655231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005-2020.
    Shin HY; Lee YY; Song SY; Park B; Suh M; Choi KS; Jun JK
    J Gynecol Oncol; 2022 Jul; 33(4):e39. PubMed ID: 35320888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach.
    Dhanasekaran K; Verma C; Kumar V; Hariprasad R; Gupta R; Gupta S; Mehrotra R
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1265-1269. PubMed ID: 31030504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.